&nbsp;

ColoQMP-QIResources-PatientDischargeGuidelines.pdf

Dec 1969

Regimen

NIVL+IPIL

Cancer Type:

Lung,

Mesothelioma (Pleural)

Intent: Palliative

Funding:

New Drug Funding Program

Nivolumab plus Ipilimumab - Advanced Malignant Pleural Mesothelioma

New Drug Funding Program

Nivolumab plus Ipilimumab - Advanced Malignant Pleural Mesothelioma

Drugs Used:

nivolumab,

ipilimumab

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Nov 2024

Regimen

CISPPEME

Cancer Type:

Gastrointestinal,

Mesothelioma (Peritoneal)

Intent: Palliative

Drugs Used:

pemetrexed,

CISplatin

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Regimen

CLAD

Cancer Type:

Hematologic,

Rare Diseases

Intent: Palliative

Drugs Used:

cladribine

Quick Link(s):

Regimen Monograph

Jul 2021

Regimen

CRBPPACL+PEMB

Cancer Type:

Head and Neck,

Squamous Cell

Intent: Palliative

Funding:

New Drug Funding Program

Pembrolizumab - Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

Drugs Used:

Quick Link(s):

Regimen Monograph

Document

ColoQMP-FacilityImprovementPlan.pdf

Jul 2021

Document

ColoQMP-PhysicianReport-PhysicianLearningPlan.pdf

Jul 2021

Regimen

NIVL+IPIL

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Drugs Used:

nivolumab (Unfunded),

ipilimumab (Unfunded)

Quick Link(s):

Regimen Monograph, Patient Info Sheet

Nov 2024

Regimen

NIVL(MNT)

Cancer Type:

Skin,

Melanoma

Intent: Adjuvant

Drugs Used:

nivolumab (Unfunded)

Quick Link(s):

Regimen Monograph

Document

CCOPEBCConflictInterestPolicy.pdf

Oct 2021

Regimen

CRBPPACL

Cancer Type:

Gynecologic,

Vulva

Intent: Palliative

Drugs Used:

PACLitaxel,

CARBOplatin